Sharada Kolekar

664 total citations
13 papers, 427 citations indexed

About

Sharada Kolekar is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sharada Kolekar has authored 13 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Oncology. Recurrent topics in Sharada Kolekar's work include PI3K/AKT/mTOR signaling in cancer (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Melanoma and MAPK Pathways (4 papers). Sharada Kolekar is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Melanoma and MAPK Pathways (4 papers). Sharada Kolekar collaborates with scholars based in New Zealand, Australia and Singapore. Sharada Kolekar's co-authors include Peter R. Shepherd, Gordon W. Rewcastle, Bruce C. Baguley, Stephen M. F. Jamieson, Jack U. Flanagan, Woo Jung Lee, William A. Denny, Christina M. Buchanan, Jackie D. Kendall and Ripudaman Singh and has published in prestigious journals such as Biochemical Journal, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Sharada Kolekar

13 papers receiving 424 citations

Peers

Countries citing papers authored by Sharada Kolekar

Since Specialization

Citations

This map shows the geographic impact of Sharada Kolekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharada Kolekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharada Kolekar more than expected).

Fields of papers citing papers by Sharada Kolekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharada Kolekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharada Kolekar. The network helps show where Sharada Kolekar may publish in the future.

Co-authorship network of co-authors of Sharada Kolekar

This figure shows the co-authorship network connecting the top 25 collaborators of Sharada Kolekar. A scholar is included among the top collaborators of Sharada Kolekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharada Kolekar. Sharada Kolekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models 2022 ·Molecular Cancer Therapeutics ·Khanh Bao Tran, Sharada Kolekar, (unknown), (unknown), Christina M. Buchanan, Sanjeev Deva, Peter R. Shepherd	7
2	Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK 2021 ·BMC Cancer ·Khanh Bao Tran, Sharada Kolekar, (unknown), Patrick Jaynes, (unknown), Qian Wang, Jack U. Flanagan, Gordon W. Rewcastle, Bruce C. Baguley, Peter R. Shepherd	25
3	Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma 2020 ·Pigment Cell & Melanoma Research ·Khanh Bao Tran, Grégory Gimenez, Peter Tsai, Sharada Kolekar, Euan J. Rodger, Aniruddha Chatterjee, (unknown), (unknown), Wayne R. Joseph, Elaine S. Marshall, Qian Wang, Cristin G. Print, Michael R. Eccles, Bruce C. Baguley, Peter R. Shepherd	12
4	Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors 2017 ·Oncotarget ·Gordon W. Rewcastle, Sharada Kolekar, Christina M. Buchanan, Swarna A. Gamage, (unknown), Kit Yee Tsang, Jackie D. Kendall, Ripudaman Singh, Woo Jung Lee, Greg C. Smith, Weiping Han, David J. Matthews, William A. Denny, Peter R. Shepherd, Stephen M. F. Jamieson	12
5	Novel pyrazolo[1,5-a]pyridines with improved aqueous solubility as p110α-selective PI3 kinase inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Jackie D. Kendall, (unknown), Kit Yee Tsang, Elaine S. Marshall, Claire L. Lill, Woo Jung Lee, Sharada Kolekar, (unknown), (unknown), (unknown), Claire Chaussade, Christina M. Buchanan, Stephen M. F. Jamieson, Gordon W. Rewcastle, Bruce C. Baguley, William A. Denny, Peter R. Shepherd	8
6	Exploring the isoform selectivity of TGX-221 related pyrido[1,2-a]pyrimidinone-based Class IA PI 3-kinase inhibitors: Synthesis, biological evaluation and molecular modelling 2015 ·Bioorganic & Medicinal Chemistry ·Andrew J. Marshall, Claire L. Lill, (unknown), Sharada Kolekar, Woo Jung Lee, Elaine S. Marshall, Bruce C. Baguley, Peter R. Shepherd, William A. Denny, Jack U. Flanagan, Gordon W. Rewcastle	13
7	Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth 2015 ·Frontiers in Oncology ·(unknown), (unknown), Sharada Kolekar, Gordon W. Rewcastle, Bruce C. Baguley, Peter R. Shepherd, Stephen M. F. Jamieson	54
8	Synthesis and biological evaluation of novel phosphatidylinositol 3-kinase inhibitors: Solubilized 4-substituted benzimidazole analogs of 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474) 2013 ·European Journal of Medicinal Chemistry ·Gordon W. Rewcastle, Swarna A. Gamage, Jack U. Flanagan, Jackie D. Kendall, William A. Denny, Bruce C. Baguley, Christina M. Buchanan, (unknown), Philip Kestell, Sharada Kolekar, Woo Jung Lee, Claire L. Lill, (unknown), Ripudaman Singh, Stephen M. F. Jamieson, Peter R. Shepherd	18
9	Novel pyrazolo[1,5-a]pyridines as PI3K inhibitors: variation of the central linker group 2013 ·MedChemComm ·Jackie D. Kendall, Andrew J. Marshall, (unknown), Kit Yee Tsang, Maruta Boyd, Raphaël Frédérick, Claire L. Lill, Woo Jung Lee, Sharada Kolekar, (unknown), (unknown), (unknown), Claire Chaussade, Christina M. Buchanan, Gordon W. Rewcastle, Bruce C. Baguley, Jack U. Flanagan, William A. Denny, Peter R. Shepherd	12
10	Novel pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR 2011 ·Bioorganic & Medicinal Chemistry ·Jackie D. Kendall, (unknown), Kit Yee Tsang, Raphaël Frédérick, Elaine S. Marshall, Ripudaman Singh, Claire L. Lill, Woo Jung Lee, Sharada Kolekar, (unknown), (unknown), (unknown), Claire Chaussade, Christina M. Buchanan, Gordon W. Rewcastle, Bruce C. Baguley, Jack U. Flanagan, Stephen M. F. Jamieson, William A. Denny, Peter R. Shepherd	30
11	Discovery of pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·Jackie D. Kendall, P. D. T. O’Connor, Andrew J. Marshall, Raphaël Frédérick, Elaine S. Marshall, Claire L. Lill, Woo Jung Lee, Sharada Kolekar, (unknown), (unknown), (unknown), Claire Chaussade, Christina M. Buchanan, Gordon W. Rewcastle, Bruce C. Baguley, Jack U. Flanagan, Stephen M. F. Jamieson, William A. Denny, Peter R. Shepherd	24
12	A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types 2011 ·Biochemical Journal ·Stephen M. F. Jamieson, Jack U. Flanagan, Sharada Kolekar, Christina M. Buchanan, Jackie D. Kendall, Woo Jung Lee, Gordon W. Rewcastle, William A. Denny, Ripudaman Singh, James M. Dickson, Bruce C. Baguley, Peter R. Shepherd	121
13	Synthesis and Biological Evaluation of Novel Analogues of the Pan Class I Phosphatidylinositol 3-Kinase (PI3K) Inhibitor 2-(Difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474) 2011 ·Journal of Medicinal Chemistry ·Gordon W. Rewcastle, Swarna A. Gamage, Jack U. Flanagan, Raphaël Frédérick, William A. Denny, Bruce C. Baguley, Philip Kestell, Ripudaman Singh, Jackie D. Kendall, Elaine S. Marshall, Claire L. Lill, Woo Jung Lee, Sharada Kolekar, Christina M. Buchanan, Stephen M. F. Jamieson, Peter R. Shepherd	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact